RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FOURCADE A
Collezione AOU Città della Salute di Torino

Items : 9

Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2025 Mar;28(1):173-179. doi: 10.1038/s41391-024-00872-6. Epub 2024 Ju

2025
AOU Città della Salute di Torino

Assenmacher G; Windisch O; Benamran D; Taha F; Barry Delongchamps N; Bui AP; Anract J; Delavar G; Dariane C; Rysankova K; Halinski A; Fiard G; Ploussard G; Abou Zahr R; Roche JB; Mastrorosa A; Bernal-Gomez A; Gontero P; Oderda M; Fournier G; Fourcade A; Simone G; Ferriero M; Lefebvre Y; Bourgeno HA; Baudewyns A; Jabbour T; Haddad L; Mjaess G; et alii...

Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection. in European urology focus / Eur Urol Focus. 2024 Sep;10(5):805-811. doi: 10.1016/j.euf.2024.03.003. Epub 2024 Mar 19.

2024
AOU Città della Salute di Torino

Halinski A; Dariane C; Barry Delongchamps N; Delavar G; Anract J; Benamran D; Novello Q; Windisch O; Ploussard G; Abou Zahr R; Fiard G; Roche JB; Mastrorosa A; Bernal-Gomez A; Rysankova K; Gontero P; Oderda M; Taha F; Bui AP; Fournier G; Fourcade A; Simone G; Ferriero M; Lefebvre Y; Mjaess G; Guenzel K; Diamand R; Benijts J; Assenmacher G; et alii...

The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score. in World journal of urology / World J Urol. 2024 May 15;42(1):322. doi: 10.1007/s00345-024-04962-x.

2024
AOU Città della Salute di Torino

Baudewyns A; Guenzel K; Halinski A; Dariane C; Delavar G; Anract J; Barry Delongchamps N; Jabbour T; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Oderda M; Gontero P; Bernal-Gomez A; Mastrorosa A; Roche JB; Zahr RA; Ploussard G; Fiard G; Rysankova K; Bui AP; Taha F; Windisch O; Benamran D; Vlahopoulos L; Assenmacher G; et alii...

External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification. in World journal of urology / World J Urol. 2024 Jun 12;42(1):372. doi: 10.1007/s00345-024-05068-0.

2024
AOU Città della Salute di Torino

Diamand R; Guenzel K; Jabbour T; Baudewyns A; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Bui AP; Taha F; Oderda M; Gontero P; Rysankova K; Bernal-Gomez A; Mastrorosa A; Roche JB; Fiard G; Abou Zahr R; Ploussard G; Windisch O; Novello Q; Benamran D; Delavar G; Anract J; Barry Delongchamps N; Halinski A; Dariane C; et alii...

The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy. in European urology oncology / Eur Urol Oncol. 2024 Dec;7(6):1320-1326. doi: 10.1016/j.euo.2024.01.007. Epub 2024 Jan 24.

2024
AOU Città della Salute di Torino

Vlahopoulos L; Guenzel K; Assenmacher G; Benamran D; Taha F; Windisch O; Bui AP; Barry Delongchamps N; Anract J; Delavar G; Dariane C; Rysankova K; Halinski A; Fiard G; Abou Zahr R; Ploussard G; Roche JB; Mastrorosa A; Bernal-Gomez A; Gontero P; Oderda M; Fournier G; Fourcade A; Simone G; Ferriero M; Lefebvre Y; Baudewyns A; Bourgeno HA; Jabbour T; et alii...

Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy. in World journal of urology / World J Urol. 2023 May;41(5):1285-1291. doi: 10.1007/s00345-023-04371-6. Epub 2023 Mar 27.

2023
AOU Città della Salute di Torino

Descotes JL; Van Damme J; Simone G; Saussez T; Roumeguère T; Peltier A; Oderda M; Gontero P; Mastroianni R; Fournier G; Fourcade A; Feyaerts A; Dariane C; Barry Delongchamps N; Assenmacher G; Albisinni S; Anract J; Roumiguié M; Seigneurin A; Fiard G; Ploussard G; Diamand R;

Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach. in World journal of urology / World J Urol. 2023 May;41(5):1301-1308. doi: 10.1007/s00345-023-04353-8. Epub 2023 Mar 15.

2023
AOU Città della Salute di Torino

Lechevallier E; Bastide C; Charvet AL; Gondran-Tellier B; Dariane C; Fromont G; Barret E; Oderda M; Sanguedolce F; Roumiguié M; Durand-Labrunie C; Fiard G; Fourcade A; Windisch O; Benamran D; Simone G; Diamand R; Beauval JB; Lacetera V; Touzani A; Roche JB; Uleri A; Roumeguère T; Breda A; Baboudjian M; Palou J; Ruffion A; Van Der Bergh RCN; Peltier A; et alii...

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications. in Urologic oncology / Urol Oncol. 2021 May;39(5):296.e1-296.e9. doi: 10.1016/j.urolonc.2020.08.030. Epub 2020 Oct 9.

2021
AOU Città della Salute di Torino

Peltier A; Simone G; Descotes JL; Fiard G; Iselin C; Benamran D; Fournier G; Fourcade A; Gontero P; Oderda M; Malavaud B; Roumiguié M; Ploussard G; Diamand R; Roche JB; Roumeguère T; Albisinni S;

External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study. in Urologic oncology / Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26.

2020
AOU Città della Salute di Torino

Bonnal JL; Van Damme J; Roche JB; Di Cosmo G; Simone G; Peltier A; Svistakov I; Assenmacher G; Descotes JL; Fiard G; Iselin C; Benamran D; Fournier G; Fourcade A; Albisinni S; Oderda M; Diamand R; Rossi M; Mandron E; Gontero P; Roumeguère T;